Both in Pharmaceuticals
Equillium vs NRX Pharmaceuticals
Over the past year EQ returned +5.2% and NRXP returned −11.5%; their daily moves had a correlation of 0.08.
EQ +5.2% NRXP −11.5%Growth of $1, one year, split-adjusted
| Metric | EQ | NRXP |
|---|---|---|
| Price | $1.42 | $2.66 |
| Market cap | $111.3M | $115.0M |
| Today | 0.00% | −1.30% |
| 1 month | −12.6% | −9.1% |
| 6 months | −30.4% | −10.9% |
| Year to date | −8.4% | −2.0% |
| 1 year | +5.2% | −11.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 38.7% |
| Net margin | — | −1500.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 33.9× |
| Net cash | $57.2M | $26.3M |
| Dividend yield | — | — |
| Volatility (60d) | 90.0% | 57.4% |
| Short % of float | 12.6% | 29.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).